Abbott Laboratories (ABT) FCF Payout Ratio (QoQ) (2009 - 2026)
Analysis
Abbott Laboratories (ABT) FCF Payout Ratio (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.84 Bn | 178.24 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.46 Bn | 119.24 Bn | 1.96 Bn |
| 3 | Medtronic | 118.36 Bn | 109.54 Bn | 6.34 Bn |
| 4 | Stryker | 105.10 Bn | 101.62 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.60 Bn | 66.06 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.47 Bn | 1.35 Bn |
| 7 | Alcon | 33.92 Bn | 32.46 Bn | 1.68 Bn |
| 8 | Dexcom | 32.31 Bn | 30.36 Bn | 830.00 Mn |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.14 Bn | 17.73 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.83% |
| Mar 31, 2026 | 205.61% |
| Dec 31, 2025 | -12.84% |
| Sep 30, 2025 | -32.43% |
| Jun 30, 2025 | -39.44% |
| Mar 31, 2025 | 146.57% |
| Dec 31, 2024 | -0.16% |
| Sep 30, 2024 | -33.67% |
| Jun 30, 2024 | -55.88% |
| Mar 31, 2024 | 292.41% |
| Dec 31, 2023 | -42.31% |
| Sep 30, 2023 | -47.27% |
| Jun 30, 2023 | 9.63% |
| Mar 31, 2023 | 143.21% |
| Dec 31, 2022 | 34.30% |
| Sep 30, 2022 | -12.40% |
| Jun 30, 2022 | -14.54% |
| Mar 31, 2022 | 46.65% |
| Dec 31, 2021 | -9.03% |
| Sep 30, 2021 | -23.63% |